NASDAQ : TGTX

TG Therapeutics, Inc.

$56.41 USD

$1.52 (2.77%)

Volume
1.6M
Average Volume
2.4M
Market Capitalization
$8.64B
P/E Ratio
17.74
Dividend Yield
0.00%
Price Target
$76.50
Year High
$59.30
Year Low
$25.28
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.81

TGTX Estimated and Actual Revenue by Quarter

TGTX Estimated and Actual EPS by Quarter

TGTX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 2 -109.73M -106.02M -108.12M -109.95M -106.23M -108.33M
2027-09-30 2 -100.31M -96.92M -98.83M -100.51M -97.11M -99.03M
2027-06-30 2 -93.42M -90.27M -92.05M -93.61M -90.45M -92.24M
2027-03-31 2 -85.95M -83.04M -84.69M -86.12M -83.21M -84.86M
2026-12-31 2 -81.44M -78.69M -80.24M -81.61M -78.85M -80.41M
2026-09-30 5 -74.53M -73.82M -74.18M -74.68M -73.97M -74.33M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 2 107.73M 112.66M 110.52M 3.83B 3.96B 3.9B
2027-09-30 2 118.93M 124.37M 122.01M 3.5B 3.62B 3.57B
2027-06-30 2 104.19M 108.95M 106.88M 3.26B 3.37B 3.32B
2027-03-31 2 81.84M 85.59M 83.96M 3B 3.1B 3.06B
2026-12-31 2 76.87M 80.38M 78.86M 2.84B 2.94B 2.9B
2026-09-30 5 47.08M 84.07M 62.21M 2.66B 2.69B 2.68B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 2 349.07M 361.28M 355.97M 2 0.67305 0.70384 0.69045
2027-09-30 2 319.1M 330.26M 325.41M 1 0.74304 0.77703 0.76225
2027-06-30 2 297.2M 307.6M 303.07M 1 0.65092 0.6807 0.66775
2027-03-31 2 273.42M 282.99M 278.83M 2 0.51133 0.53472 0.52455
2026-12-31 2 259.08M 268.14M 264.2M 2 0.48024 0.50221 0.49266
2026-09-30 5 243.06M 245.39M 244.25M 4 0.29414 0.52526 0.38869